These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 15623660)

  • 1. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis.
    Castellana D; Zobairi F; Martinez MC; Panaro MA; Mitolo V; Freyssinet JM; Kunzelmann C
    Cancer Res; 2009 Feb; 69(3):785-93. PubMed ID: 19155311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
    Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A
    Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
    Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors.
    Qi L; Robinson WA; Brady BM; Glode LM
    Anticancer Res; 2003; 23(5A):3917-22. PubMed ID: 14666697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion.
    Singh S; Singh UP; Grizzle WE; Lillard JW
    Lab Invest; 2004 Dec; 84(12):1666-76. PubMed ID: 15467730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
    Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
    Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.
    Wilson SR; Gallagher S; Warpeha K; Hawthorne SJ
    Prostate; 2004 Jul; 60(2):168-74. PubMed ID: 15162383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
    Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
    Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
    Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
    Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.